Series C brings in $150mm for Valeritas
Executive Summary
Valeritas Inc. (insulin delivery technology) has raised a whopping $150mm in its Series C venture round led by Welsh, Carson, Anderson & Stowe, which takes a controlling interest in the company following the financing. The investment firm's Daniel Pelaki will become chairman of the company’s board. Also contributing were returning shareholders Abingworth, Advanced Technology Ventures, Agate Medical Investments, CHL Medical Partners, HLM Venture Partners, Kaiser Permanente Ventures, MPM Capital, Onset Ventures, and Pitango Venture Capital.
Deal Industry
- Medical Devices
-
Pharmaceuticals
-
Drug Delivery
- Controlled Release
- Macromolecule
- Transdermal
-
Drug Delivery
-
Biotechnology
- Large Molecule
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice